Complete Wegovy and Mounjaro Dosing Comparison Guide
Understanding Wegovy and Mounjaro Equivalent Doses for Prescription Weight Loss
When comparing Wegovy and Mounjaro equivalent doses, it's essential to understand these are fundamentally different medications with distinct dosing approaches. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. The dosing schedules cannot be directly converted as equivalent doses, as each medication works through different mechanisms and requires specific escalation patterns to optimise both efficacy and tolerability.
Wegovy follows a precise 16-week dose escalation: starting at 0.25mg weekly, progressing through 0.5mg, 1mg, 1.7mg, and reaching the maintenance dose of 2.4mg. Mounjaro begins at 2.5mg weekly, increasing every four weeks through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum of 15mg. Both prescription-only medicines require careful clinical supervision to determine the appropriate dosing progression for individual patients seeking effective weight management solutions.
Wegovy and Mounjaro Pricing: Complete Dose-by-Dose Breakdown
Understanding the cost implications when comparing Wegovy and Mounjaro equivalent doses helps patients plan their prescription weight loss journey effectively. Wegovy pricing at EverydayMeds starts with our 0.25mg starter dose at £79.99, progressing to 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the maintenance 2.4mg dose at £209.99. New customers benefit from our FIRST40 discount code, while returning patients use DOSE25, both applied at checkout to reach these final prices.
Our bundle options provide convenient multi-month supplies without the need for frequent reordering. The Intro Trio bundle (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first 12 weeks of treatment. For patients reaching maintenance dosing, our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. These bundles ensure treatment continuity whilst simplifying the ordering process for busy patients committed to long-term weight management.
Clinical Evidence: How Wegovy and Mounjaro Compare in Weight Management Trials
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks in the primary STEP 1 trial (Wilding et al., NEJM, 2021). The STEP 2 trial showed that patients with type 2 diabetes experienced around 9.6% average weight loss, whilst STEP 3 participants receiving intensive behavioural therapy achieved approximately 16% weight reduction.
Mounjaro's SURMOUNT trials showed different results due to its dual mechanism of action, but direct comparison of trial outcomes isn't appropriate given different study designs, populations, and endpoints. Both medications have demonstrated significant cardiovascular benefits, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events. Your prescriber can discuss which evidence base aligns best with your individual health profile and weight management goals.
Wegovy Mechanism: How This GLP-1 Treatment Supports Weight Loss
Wegovy works by mimicking GLP-1, a natural hormone that regulates appetite and blood sugar levels. When injected weekly, semaglutide binds to GLP-1 receptors in the brain, particularly in areas controlling hunger and satiety. This mechanism reduces appetite, promotes feelings of fullness after smaller meals, and may decrease food cravings by working directly on brain appetite centres. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety between meals. Unlike Mounjaro's dual mechanism, Wegovy focuses specifically on GLP-1 pathways, providing targeted appetite regulation that supports sustainable weight management when combined with lifestyle modifications.
Starting Your Wegovy Journey: From Assessment to Delivery
Beginning treatment requires completing our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review your application within three working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate for your individual circumstances. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy #9012878 and shipped via next-day delivery using temperature-controlled cold-chain packaging. The process includes detailed injection guidance, dosing schedules, and ongoing clinical support throughout your treatment journey. Our pharmacy team remains available for questions about dose escalation, side effect management, and treatment optimisation.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers significant practical advantages in storage and travel convenience compared to Mounjaro equivalent doses. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, whilst Mounjaro only maintains stability for 21 days at room temperature. Both medications require refrigerated storage (2-8°C) before first use, but Wegovy's extended room temperature stability makes it more suitable for frequent travellers or patients with varying refrigeration access. The FlexTouch pen design provides precise dosing with clear dose windows, and the mandatory dose escalation schedule helps minimise gastrointestinal side effects commonly experienced with GLP-1 treatments. Each pen contains four doses, providing one month's treatment per pen.
Personalised Dosing: Why Wegovy and Mounjaro Equivalence Matters Less Than Individual Response
Rather than seeking exact Wegovy and Mounjaro equivalent doses, successful prescription weight loss depends on individualised treatment selection based on your specific health profile, tolerability, and response patterns. Some patients respond optimally to Wegovy's GLP-1-focused approach, whilst others may benefit from Mounjaro's dual receptor mechanism. Your prescriber evaluates factors including existing medical conditions, concurrent medications, previous weight loss attempts, and personal preferences when selecting between these treatments.
Both medications require commitment to the prescribed dosing schedule alongside reduced-calorie diet and increased physical activity for optimal results. The key isn't finding equivalent doses, but rather identifying which medication and dosing approach aligns with your lifestyle, medical needs, and weight management objectives. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment pathway offers the best potential for your individual circumstances.
Order Your Prescription Weight Loss Treatment Today
Ready to begin your clinically-supervised weight management journey with professional guidance on Wegovy and Mounjaro dosing options? Start with our 3-minute assessment at EverydayMeds, where our qualified prescribers will evaluate which treatment approach suits your individual needs. New customers save with discount code FIRST40, whilst returning patients benefit from DOSE25, both applied automatically at checkout. Our comprehensive service includes expert clinical oversight, convenient bundle options, and reliable next-day delivery from our GPhC-registered pharmacy #9012878. Don't delay your weight management goals – begin your assessment today and take the first step towards clinically-proven prescription weight loss support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
